Chronic Loose Stools Following Right-sided Hemicolectomy for Colon Cancer and the Association With Bile Acid Malabsorption and Small Intestinal Bacterial Overgrowth Using a Novel Sampling Device
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT06927011
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 20 Years - 85 Years
- Healthy Volunteers
- Not accepted
Interventions
- Capscan — BEHAVIORALParticipants will be asked to swallow 2 small devices (called Capscan), which will collect samples of intestinal fluid as they move through participants small intestine and colon. This device is not FDA approved but has been deemed to have no significant risk. The investigator can explain how it is designed to work. Participants will also answer surveys about participants quality of life. Participants in this study will be over after all study procedures are completed.
Study Details
The goal of this clinical research study is to learn about gastrointestinal symptoms in participants who have undergone SC or RC and their impact on the quality of life of these participants.
Key Dates
- First listed
- Apr 15, 2025
- Start date
- Oct 31, 2025
- Status verified
- Jul 2026
- Primary completion
- Dec 30, 2026
- Completion
- Dec 30, 2028
Study Design
- Enrollment
- 20 participants (estimated)
Arms
- Arm: Colon CancerParticipants will be asked to swallow 2 small devices (called Capscan), which will collect samples of intestinal fluid as they move through participants small intestine and colon. This device is not FDA approved but has been deemed to have no significant risk. The investigator can explain how it is designed to work. Participants will also answer surveys about participants quality of life. Participants in this study will be over after all study procedures are completed.
Primary Outcome Measure
Overall Survival (OS) [ Time Frame: Through study completion; an average of 1 year. ]
Central Contacts
- Anusha Thomas, MBBS(713) 794-1439
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MD Anderson Cancer Center | Houston | Texas | 77030 | Anusha Thomas, MBBS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By condition
By specialty
By research site
Related Studies
- COLON-MD: Colon Cancer Longitudinal StudyRecruiting · Baylor Research Institute · Temple, Texas
- Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsPHASE1/PHASE2 · Recruiting · ModeX Therapeutics, An OPKO Health Company · Denver, Colorado
- A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)PHASE2 · Recruiting · SCRI Development Innovations, LLC · Denver, Colorado
- A Study of PHN-012 in Patients With Advanced Solid TumorsPHASE1 · Recruiting · Pheon Therapeutics · Los Angeles, California